Ou-Chen Wang (Ouchen Wang)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 6

Top Topics

Long Noncoding Rna

Papillary Thyroid

Top Venues

Cell biochemistry and function

Clinical and experimental pharmacology & physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Chen Zheng, Er-Jie Xia, Rui-Da Quan, Adheesh Bhandari, Ou-Chen Wang, Ru-Tian Hao
Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition. Cell biochemistry and function 38 (2) (2020)
Yuying Zhou, Jingjing Xiang, Adheesh Bhandari, Jialiang Wen, Bangyi Lin, Lingguo Kong, Ou-Chen Wang
LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer. Clinical and experimental pharmacology & physiology 47 (4) (2020)
Yaoyao Guan, Yinghao Wang, Adheesh Bhandari, Erjie Xia, Ou-Chen Wang
IGSF1: A novel oncogene regulates the thyroid cancer progression. Cell biochemistry and function 37 (7) (2019)
Yinghao Wang, Adheesh Bhandari, Jizhao Niu, Fan Yang, Erjie Xia, Zhihan Yao, Yixiang Jin, Zhouci Zheng, Shixu Lv, Ou-Chen Wang
The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Human cell 32 (3) (2019)
Yaoyao Guan, Adheesh Bhandari, Erjie Xia, Fan Yang, Jingjing Xiang, Ou-Chen Wang
lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer. Cell biochemistry and function 37 (4) (2019)
Chuanmeng Pan, Adheesh Bhandari, Yehuan Liu, Erjie Xia, Lizhi Lin, Shixu Lv, Ou-Chen Wang
KLP-PI: a new prognostic index for luminal B HER-2-negative breast cancer. Human cell 32 (2) (2018)